Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,158 | 0,162 | 14:10 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.07. | IMPLANET Announces CFDA Approval for Its Innovative JAZZ Range in China | 220 | Business Wire | Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, PEA-PME eligible), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced... ► Artikel lesen | |
08.07. | IMPLANET Announces Half-Year Revenue for 2025 up 41% to €5.8 Million | 846 | Business Wire | Second quarter 2025 up +71% to €3.2 millions
Revenue in the United States increased by a factor of 5.4 in Q2 2025 and by 1.7x for the first half of 2025 compared to 2024
Strong first... ► Artikel lesen | |
24.04. | IMPLANET to Co-Exhibit its Innovative Spine Solutions Alongside 8i Robotics' Next-Gen Robotic Solutions at AANS in Boston | 277 | Business Wire | Spine tech innovator IMPLANET will demo and display its game-changing portfolio in tandem with 8i Robotics' robot systems at Booth #1029, April 25-28, 2025
Regulatory News:
At this year's American... ► Artikel lesen | |
14.04. | Minutes of IMPLANET's Annual General Meeting Held on April 11, 2025 | 438 | Business Wire | Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, éligible PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced... ► Artikel lesen | |
09.04. | IMPLANET Reports Revenue of €2.58 Million in Q1 2025, Up +16% | 276 | Business Wire | +16% revenue growth compared to Q1 2024
Performance driven by strong export growth outside France and the United States (+42% vs. Q1 2024)
Regulatory News:
IMPLANET (Euronext Growth:... ► Artikel lesen | |
04.03. | IMPLANET Reports Its 2024 Full-Year Results | 470 | Business Wire | 2024 full-year revenue up +26% compared to fiscal year 2023
Continued strict control of operational costs throughout the period
Regulatory News:
IMPLANET (Euronext Growth: ALIMP,... ► Artikel lesen | |
IMPLANET Aktie jetzt für 0€ handeln | |||||
14.01. | IMPLANET Announces 2024 Full-Year Revenue Up 26% to €9.4 Million | 397 | Business Wire | Continued acceleration in quarterly revenue growth since Q2 2024, with Q4 2024 reaching nearly €3.0 million, up 81% versus 2023
Strong full-year performance in the medical equipment distribution... ► Artikel lesen | |
06.01. | IMPLANET Announces Its 2025 Financial Calendar | 508 | Business Wire | Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the... ► Artikel lesen | |
05.12.24 | IMPLANET Announces Financing of Around €2 Million | 447 | Business Wire | Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the... ► Artikel lesen | |
08.10.24 | IMPLANET announces revenue of €2.3 million as of September 30, 2024, 50% growth | 444 | Business Wire | Revenue for the first nine months of 2024: €6.4 million, a 11% increase compared to the same period last year
First delivery of Olea equipment worth €0.5 million completed in the United... ► Artikel lesen | |
25.09.24 | elliquence and Implanet Form Partnership for US Distribution of Ultrasonic Bone Scalpel Olea in Endoscopic Spine Market | 457 | Business Wire | Spine tech innovators elliquence and Implanet to exhibit at NASS in Chicago, September 25-28, 2024 (elliquence LLC Booth 2419 Implanet Booth 2412)
Regulatory News:
elliquence LLC, specializing... ► Artikel lesen | |
19.09.24 | Implanet to Co-Exhibit Alongside 8i Robotics' Next-Gen Robotic Solutions at NASS1 booth #2412 in Chicago | 586 | Business Wire | Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced... ► Artikel lesen | |
10.09.24 | IMPLANET Announces Its 2024 Half-year Results | 553 | Business Wire | Revenue of €4.1 million in the first half of 2024
Sales force investment aimed at revitalizing the Company's presence in the United States
Strict management of operational expenses... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 49,350 | +1,69 % | BERENBERG stuft Siemens Healthineers auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Siemens Healthineers von 57,80 auf 57,00 Euro gesenkt, aber die Einstufung auf "Buy" belassen. 2025 sei bislang ein schwieriges... ► Artikel lesen | |
GENEDX | 91,66 | 0,00 % | GeneDx stock price target raised to $125 from $100 at BTIG on strong Q2 | ||
FRESENIUS | 42,580 | +0,66 % | Fresenius erhält EU-Zulassung für zwei Denosumab-Biosimilars | DJ Fresenius erhält EU-Zulassung für zwei Denosumab-Biosimilars
DOW JONES--Fresenius hat nach eigener Aussage die Zulassung der EU-Kommission für zwei Biosimilars in Europa erhalten.
Wie Fresenius... ► Artikel lesen | |
PHETON | 1,630 | 0,00 % | CN ADR Pheton Plummets 95% in Single Day; Report Suggests Possible Manipulation by Overseas Groups | ||
PRIVIA HEALTH GROUP | 19,480 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
LIFESTANCE HEALTH GROUP | 4,130 | 0,00 % | LifeStance Health (LFST) Appoints Vaughn Paunovich as Chief Technology Officer | ||
FRESENIUS MEDICAL CARE | 45,130 | -0,29 % | Fitch bestätigt Fresenius Medical Care mit "BBB-" - Ausblick stabil | DJ Fitch bestätigt Fresenius Medical Care mit "BBB-" - Ausblick stabil
DOW JONES--Fitch Ratings hat die Langfrist-Ratings von Fresenius Medical Care (FMC) mit "BBB-" bestätigt. Der Rating-Ausblick... ► Artikel lesen | |
GERRESHEIMER | 45,140 | -2,08 % | Evotec, Gerresheimer, Hugo Boss, Puma, Renk Group, Zalando - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 53,85 | 0,00 % | PROCEPT BioRobotics President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO | Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing... ► Artikel lesen | |
MIMEDX | 6,670 | 0,00 % | SA analyst upgrades/downgrades: OXY, AMZN, MDXG, CHTR | ||
CARL ZEISS MEDITEC | 50,50 | -1,27 % | Carl Zeiss Meditec Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
ALIGNMENT HEALTHCARE | 11,780 | 0,00 % | Insights into Alignment Healthcare's Upcoming Earnings | ||
UNITEDHEALTH | 228,95 | +1,15 % | Kriminelle Machenschaften: UnitedHealth: Nun also doch! | © Foto: UnsplashIm Mai hatte der US-Krankenversicherer UnitedHealth noch dementiert, dass das US-Ministerium gegen das Unternehmen ermitteln würde, nun ist es doch so. US-Krankenversicherer in der Krise... ► Artikel lesen | |
NUTEX HEALTH | 84,90 | 0,00 % | Nutex Health, Inc.: Nutex Health Responds to Short Seller Report | HOUSTON, July 23, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system... ► Artikel lesen | |
INCANNEX HEALTHCARE | 1,060 | 0,00 % | Pre-market Movers: Linkhome, Eightco Holdings, Incannex Healthcare, Coursera, NextCure | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.35 A.M. ET).In the Green Linkhome Holdings Inc. (LHAI) is up over 120% at $12.40.
Eightco... ► Artikel lesen |